Yahoo
NasdaqGS - Delayed Quote USD

10x Genomics, Inc. (TXG)

62.65 -0.57 (-0.90%)
At close: September 4 at 4:00:00 PM EDT
62.39 -0.26 (-0.42%)
After hours: September 4 at 7:30:03 PM EDT
Trade TXG on Coinbase

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
8.23B 5.00B 2.74B 2.08B 1.48B 1.44B
Enterprise Value
7.76B 4.54B 2.30B 1.69B 1.12B 1.09B
Trailing P/E
-- -- -- -- -- --
Forward P/E
1.25k 625.00 -- -- -- --
PEG Ratio (5yr expected)
-- -- -- -- -- --
Price/Sales
13.08 7.57 4.12 3.14 2.22 2.25
Price/Book
9.97 6.13 3.44 2.65 1.91 2.04
Enterprise Value/Revenue
12.58 7.10 3.58 2.63 1.74 1.75
Enterprise Value/EBITDA
148.50 121.02 588.22 -- -- --
6/30/2025 - 9/12/2019

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin -12.18%
Operating Margin (ttm) -15.20%

Management Effectiveness

Return on Assets (ttm) -5.05%
Return on Equity (ttm) -9.40%

Income Statement

Revenue (ttm) 616.91M
Revenue Per Share (ttm) 4.83
Quarterly Revenue Growth (yoy) -12.70%
Gross Profit (ttm) 432.53M
EBITDA -41.2M
Net Income Avi to Common (ttm) -75.12M
Diluted EPS (ttm) -0.60
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 552.03M
Total Cash Per Share (mrq) 4.24
Total Debt (mrq) 78.8M
Total Debt/Equity (mrq) 9.54%
Current Ratio (mrq) 5.69
Book Value Per Share (mrq) 6.31

Cash Flow Statement

Operating Cash Flow (ttm) 127.08M
Levered Free Cash Flow (ttm) 179.66M

Trading Information

Stock Price History

Beta (5Y Monthly) 2.08
52 Week Change 3 349.75%
S&P 500 52-Week Change 3 18.84%
52 Week High 3 66.94
52 Week Low 3 11.16
50-Day Moving Average 3 50.87
200-Day Moving Average 3 28.94

Share Statistics

Avg Vol (3 month) 3 3.14M
Avg Vol (10 day) 3 2.55M
Shares Outstanding 5 120.21M
Implied Shares Outstanding 6 130.29M
Float 8 118.1M
% Held by Insiders 1 1.52%
% Held by Institutions 1 112.01%
Shares Short (8/14/2026) 4 15.93M
Short Ratio (8/14/2026) 4 4.97
Short % of Float (8/14/2026) 4 17.93%
Short % of Shares Outstanding (8/14/2026) 4 12.22%
Shares Short (prior month 7/15/2026) 4 16.25M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: